Zobrazeno 1 - 10
of 73
pro vyhledávání: '"ChaoYong Liu"'
Publikováno v:
Advanced Science, Vol 11, Iss 43, Pp n/a-n/a (2024)
Abstract Ionic liquids (ILs) are salts with melting points typically
Externí odkaz:
https://doaj.org/article/35cbeb7cc5224ed6819472976a7e511e
Autor:
Yongchao Gao, Hanchen Zhang, Lin Tang, Feifei Li, Li Yang, Haihua Xiao, Johannes Karges, Weihua Huang, Wei Zhang, Chaoyong Liu
Publikováno v:
Advanced Science, Vol 11, Iss 4, Pp n/a-n/a (2024)
Abstract Poor immunogenicity seriously hampers the broader implementation of antitumor immunotherapy. Enhanced immunogenicity capable of achieving greater antitumor immunity is urgently required. Here, a novel polymer that contains hydrophobic ferroc
Externí odkaz:
https://doaj.org/article/39ec65a897da43c590aac496dd00cde9
Publikováno v:
Advanced NanoBiomed Research, Vol 3, Iss 7, Pp n/a-n/a (2023)
Cancer vaccines stimulate the immune system within the body by introducing tumor antigens in various forms, such as tumor cells, tumor‐related proteins or peptides, and genes expressing tumor antigens, into the body. This activation of the immune r
Externí odkaz:
https://doaj.org/article/57b1a771621c47bdaa7d6708f17ab695
Autor:
Lingpu Zhang, Lin Zhu, Lin Tang, Jiayi Xie, Yajuan Gao, Changyuan Yu, Kun Shang, Hongbin Han, Chaoyong Liu, Yunfeng Lu
Publikováno v:
Advanced Science, Vol 10, Iss 3, Pp n/a-n/a (2023)
Abstract Camptothecin (CPT) is a potent chemotherapeutic agent for various cancers, but the broader application of CPT is still hindered by its poor bioavailability and systemic toxicity. Here, a prodrug that releases CPT in response to glutathione (
Externí odkaz:
https://doaj.org/article/04e7bdc84b844aa0bcb71427e4b16b77
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccines can prevent many millions of illnesses against infectious diseases and save numerous lives every year. However, traditional vaccines such as inactivated viral and live attenuated vaccines cannot adapt to emerging pandemics due to their time-
Externí odkaz:
https://doaj.org/article/e25cda3a4e4a4243a452cfb296c808c3
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Glioblastoma (GBM) is the most aggressive type of brain tumor. Despite the multimodal therapies, the effectiveness of traditional treatments is not much satisfying. In recent years, immunotherapy has become the focus of tumor treatment. Unlike tradit
Externí odkaz:
https://doaj.org/article/f91cfe2dc858435990eb5359db889fbc
Autor:
Xiaoyan Qin, Yixin Wu, Shuang Liu, Lei Yang, Hongxia Yuan, Susu Cai, Julia Flesch, Zehao Li, Yujing Tang, Xiaomin Li, Yi Zhuang, Changjiang You, Chaoyong Liu, Changyuan Yu
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2022)
Polycaprolactone (PCL) has been widely used as a scaffold material for tissue engineering. Reliable applications of the PCL scaffolds require overcoming their native hydrophobicity and obtaining the sustained release of signaling factors to modulate
Externí odkaz:
https://doaj.org/article/d9a9f1107e2f414585c2b929d8263469
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Sepsis is a systemic inflammatory response syndrome caused by infections that may lead to organ dysfunction with high mortality. With the rapid increase in the aging population and antimicrobial resistance, developing therapeutics for the treatment o
Externí odkaz:
https://doaj.org/article/bc6f35f026d44b6396fc89ffc8400523
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Glioblastoma (GBM) is the most common malignant primary brain tumor with a poor prognosis. The current standard treatment regimen represented by temozolomide/radiotherapy has an average survival time of 14.6 months, while the 5-year survival rate is
Externí odkaz:
https://doaj.org/article/f9e438306a1a47058f9d9880affffa4e
Autor:
Kai Huang, Xing Liu, Yansheng Li, Qixue Wang, Junhu Zhou, Yunfei Wang, Feng Dong, Chao Yang, Zhiyan Sun, Chuan Fang, Chaoyong Liu, Yanli Tan, Xudong Wu, Tao Jiang, Chunsheng Kang
Publikováno v:
Advanced Science, Vol 6, Iss 17, Pp n/a-n/a (2019)
Abstract Amplification of epidermal growth factor receptor (EGFR) and active mutant EGFRvIII occurs frequently in glioblastoma (GBM) and contributes to chemo/radio‐resistance in various cancers, especially in GBM. Elucidating the underlying molecul
Externí odkaz:
https://doaj.org/article/2391bfe77a5a4d99bf4ec60285242202